Thus, it remains essential to diagnose and treat HES when patients present with peripheral hypereosinophilia(>1.5x 10 9 /L on 2 examinations separated in time by at least 1 month) with tissue hypereosinophilia(20% eosinophils on bone marrow biopsy, or significant eosinophilic tissue infiltration) and with organ damage or dysfunction.